Meridian Bioscience Reports Fourth Quarter And Full-Year Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2016 Guidance

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO):

GENERAL HIGHLIGHTS

Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today:

• reported fourth quarter and record full-year fiscal 2015 net revenues of $47.1 million and $194.8 million, respectively, increases of 1% and 3%, respectively, from the same periods of the prior fiscal year;

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC